Literature DB >> 15241746

The spectrum of cardiovascular disease in children with predialysis chronic kidney disease.

Blanche M Chavers1, Charles A Herzog.   

Abstract

Cardiovascular disease is the major cause of mortality in adults and children on chronic dialysis and in adults after kidney transplantation. Cardiovascular disease burden and cardiovascular mortality are high in adults with chronic kidney disease. The early development of cardiovascular disease risk factors, some of which are modifiable, largely explain this phenomenon. Limited data are available on the prevalence of chronic kidney disease in children, the prevalence of cardiovascular disease in children with chronic kidney disease, and the prevalence of cardiovascular disease risk factors in these patients. This article summarizes the current knowledge of the prevalence of cardiovascular disease and of cardiovascular disease risk factors in pediatric patients with predialysis chronic kidney disease. Long-term prospective studies are needed to determine the impact of early identification and treatment of cardiovascular disease and its risk factors on the natural history of cardiovascular disease in children with chronic kidney disease.

Entities:  

Mesh:

Year:  2004        PMID: 15241746     DOI: 10.1053/j.arrt.2004.04.002

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  9 in total

1.  Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease.

Authors:  Bradley A Warady; Mazen Y Arar; Gary Lerner; Arline M Nakanishi; Catherine Stehman-Breen
Journal:  Pediatr Nephrol       Date:  2006-05-25       Impact factor: 3.714

2.  CRIT-LINE: a noninvasive tool to monitor hemoglobin levels in pediatric hemodialysis patients.

Authors:  Rouba Garro; Scott Sutherland; Liz Bayes; Steven Alexander; Cynthia Wong
Journal:  Pediatr Nephrol       Date:  2015-04-09       Impact factor: 3.714

3.  The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: objectives, design, and methodology.

Authors:  Uwe Querfeld; Ali Anarat; Aysun K Bayazit; Aysin S Bakkaloglu; Yelda Bilginer; Salim Caliskan; Mahmut Civilibal; Anke Doyon; Ali Duzova; Daniela Kracht; Mieczyslaw Litwin; Anette Melk; Sevgi Mir; Betül Sözeri; Rukshana Shroff; René Zeller; Elke Wühl; Franz Schaefer
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-24       Impact factor: 8.237

4.  When does the cardiovascular disease appear in patients with chronic kidney disease?

Authors:  Betul Sozeri; Sevgi Mir; Orhan Deniz Kara; Erturk Levent
Journal:  Pediatr Cardiol       Date:  2010-04-17       Impact factor: 1.655

5.  Safety and Efficacy of PDpoetin for Management of Anemia in Patients with end Stage Renal Disease on Maintenance Hemodialysis: Results from a Phase IV Clinical Trial.

Authors:  Abbas Norouzi Javidan; Heshmatollah Shahbazian; Amirhossein Emami; Mir Saeed Yekaninejad; Hassan Emami-Razavi; Masoumeh Farhadkhani; Ahmad Ahmadzadeh; Fazel Gorjipour
Journal:  Hematol Rep       Date:  2014-09-10

Review 6.  Hypertension in pediatric patients with chronic kidney disease: management challenges.

Authors:  Claire M Gallibois; Natasha A Jawa; Damien G Noone
Journal:  Int J Nephrol Renovasc Dis       Date:  2017-07-26

7.  Prevalence of Cardiovascular Disease Risk Factors in Childhood Glomerular Diseases.

Authors:  Isa F Ashoor; Sarah A Mansfield; Michelle M O'Shaughnessy; Rulan S Parekh; Jarcy Zee; Tetyana L Vasylyeva; Amy J Kogon; Christine B Sethna; Dorey A Glenn; Aftab S Chishti; Donald J Weaver; Margaret E Helmuth; Hilda E Fernandez; Michelle N Rheault
Journal:  J Am Heart Assoc       Date:  2019-07-09       Impact factor: 5.501

Review 8.  Treatment of hypertension in children and adolescents.

Authors:  Marc B Lande; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2007-08-10       Impact factor: 3.714

9.  Emergency management of hypertension in children.

Authors:  Dinesh Singh; Olugbenga Akingbola; Ihor Yosypiv; Samir El-Dahr
Journal:  Int J Nephrol       Date:  2012-04-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.